{"id":3840,"date":"2019-01-21T08:17:11","date_gmt":"2019-01-21T08:17:11","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/"},"modified":"2019-01-21T08:17:11","modified_gmt":"2019-01-21T08:17:11","slug":"teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/","title":{"rendered":"Teckningsperiod f\u00f6r teckningsoptioner (TO1) i Nanexa AB \u00e4r nu \u00f6ppen"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><span><strong><\/strong><\/span><\/p>\n<\/div>\n<p><span>Anm\u00e4lan om teckning av aktier med st\u00f6d av teckningsoptioner, noterade f\u00f6r handel p\u00e5 Spotlight Stockmarket med kortnamnet NANEXA TO1, kan nu ske. Teckningstiden l\u00f6per fr\u00e5n den 21 januari till den 1 februari. Varje teckningsoption ger r\u00e4tt att teckna en (1) ny aktie i Bolaget till en teckningskurs om 5,99 kr per aktie. Kursen motsvarar sjuttiofem (75) procent av det volymv\u00e4gda genomsnittet av kursen f\u00f6r Nanexas aktie under perioden 7 januari 2019 till den 18 januari 2019.<\/span><\/p>\n<p><span>Direktregistrerade innehavare av teckningsoptioner ska anm\u00e4la l\u00f6sen av teckningsoptioner genom att fylla i och skicka in anm\u00e4lningssedel (tillg\u00e4nglig hos respektive f\u00f6rvaltare samt hos Aqurat Fondkommission) f\u00f6r inl\u00f6sen, s\u00e5 att den \u00e4r Aqurat Fondkommission tillhanda senast fredagen den 1 februari 2019. Observera att \u00e4ven betalning f\u00f6r de nya aktierna ska vara Aqurat Fondkommission tillhanda senast den 1 februari, i enlighet med instruktioner p\u00e5 anm\u00e4lningssedeln. F\u00f6rvaltarregistrerade innehavare av teckningsoptioner ska anm\u00e4la l\u00f6sen av teckningsoptioner genom att kontakta sin f\u00f6rvaltare och f\u00f6lja sin f\u00f6rvaltares instruktion avseende betalning etc. Detta b\u00f6r ske i god tid f\u00f6re den 1 februari 2019, d\u00e5 olika f\u00f6rvaltare har olika handl\u00e4ggningstider.<\/span><\/p>\n<p><span>De innehavare som inte \u00f6nskar utnyttja sina teckningsoptioner rekommenderas att s\u00e4lja dem. Teckningsoptionerna handlas till och med den 30 januari 2019. Teckningsoptioner som inte nyttjas eller s\u00e4ljs f\u00f6rfaller utan v\u00e4rde.<\/span><\/p>\n<p><span>De nya aktierna kommer att levereras till tecknarnas konto som interimsaktier (Nanexa IA). Interimsaktierna ber\u00e4knas omvandlas till riktiga aktier s\u00e5 snart emissionen blivit registrerad hos Bolagsverket och Euroclear, vilket ber\u00e4knas vara klart under februari 2019. Ingen handel kommer att ske i interimsaktier p\u00e5 b\u00f6rsplatsen.<\/span><\/p>\n<p><span>Vid eventuella fr\u00e5gor avseende Nanexas teckningsoptioner av serie TO1, v\u00e4nligen kontakta Aqurat Fondkommission, telefon: 08-684 05 800, E-post:\u00a0<\/span><span>info@aqurat.se\u00a0<\/span><span>alternativt G\u00f6teborg Corporate Finance, telefon: 031-13 82 30, E-post:\u00a0<\/span><span>info@gcf.se<\/span><span>.<\/span><\/p>\n<p><span>Kortnamn: NANEXA TO 1 ISIN-Kod: SE0010520452<\/span><\/p>\n<p><span>F\u00f6r mer information kontakta:<br \/>David Westberg\u00a0<\/span><span>\u2013\u00a0<\/span><span>VD, Nanexa AB (publ)<\/span>\u00a0<span>Telefon: 0709 -42 83 03<\/span><span><br \/><\/span><span>E-post: david.westberg@nanexa.se www.nanexa.com<\/span><\/p>\n<p><span>Om Nanexa AB (publ)<\/span><\/p>\n<p><span>Nanexa AB \u00e4r ett nanoteknologiskt drug deliveryf\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell<\/span><span>\u00ae\u00a0<\/span><span>som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell<\/span><span>\u00ae\u00a0<\/span><span>har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/span><\/p>\n<p><\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<p><\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/mb.cision.com\/Main\/12591\/2722141\/979298.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Read as PDF<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<\/p>\n<p>Anm\u00e4lan om teckning av aktier med st\u00f6d av teckningsoptioner, noterade f\u00f6r handel p\u00e5 Spotlight Stockmarket med kortnamnet NANEXA TO1, kan nu ske. Teckningstiden l\u00f6per fr\u00e5n den 21 januari till den 1 februari.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3840","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ca_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-listing_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ca-other_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Teckningsperiod f\u00f6r teckningsoptioner (TO1) i Nanexa AB \u00e4r nu \u00f6ppen - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teckningsperiod f\u00f6r teckningsoptioner (TO1) i Nanexa AB \u00e4r nu \u00f6ppen - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Anm\u00e4lan om teckning av aktier med st\u00f6d av teckningsoptioner, noterade f\u00f6r handel p\u00e5 Spotlight Stockmarket med kortnamnet NANEXA TO1, kan nu ske. Teckningstiden l\u00f6per fr\u00e5n den 21 januari till den 1 februari.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\\\/\",\"name\":\"Teckningsperiod f\u00f6r teckningsoptioner (TO1) i Nanexa AB \u00e4r nu \u00f6ppen - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2019-01-21T08:17:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Teckningsperiod f\u00f6r teckningsoptioner (TO1) i Nanexa AB \u00e4r nu \u00f6ppen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Teckningsperiod f\u00f6r teckningsoptioner (TO1) i Nanexa AB \u00e4r nu \u00f6ppen - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/","og_locale":"sv_SE","og_type":"article","og_title":"Teckningsperiod f\u00f6r teckningsoptioner (TO1) i Nanexa AB \u00e4r nu \u00f6ppen - Nanexa AB","og_description":"Anm\u00e4lan om teckning av aktier med st\u00f6d av teckningsoptioner, noterade f\u00f6r handel p\u00e5 Spotlight Stockmarket med kortnamnet NANEXA TO1, kan nu ske. Teckningstiden l\u00f6per fr\u00e5n den 21 januari till den 1 februari.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/","url":"https:\/\/nanexa.com\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/","name":"Teckningsperiod f\u00f6r teckningsoptioner (TO1) i Nanexa AB \u00e4r nu \u00f6ppen - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2019-01-21T08:17:11+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/teckningsperiod-for-teckningsoptioner-to1-i-nanexa-ab-ar-nu-oppen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Teckningsperiod f\u00f6r teckningsoptioner (TO1) i Nanexa AB \u00e4r nu \u00f6ppen"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}